237 related articles for article (PubMed ID: 8743228)
21. Detection of cervical precancer and cancer in a hospital population; benefits of testing for human papillomavirus.
Dalstein V; Riethmuller D; Sautière JL; Prétet JL; Kantelip B; Schaal JP; Mougin C
Eur J Cancer; 2004 May; 40(8):1225-32. PubMed ID: 15110887
[TBL] [Abstract][Full Text] [Related]
22. Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population.
Ritter DB; Kadish AS; Vermund SH; Romney SL; Villari D; Burk RD
Am J Obstet Gynecol; 1988 Dec; 159(6):1517-25. PubMed ID: 2849881
[TBL] [Abstract][Full Text] [Related]
23. A comparison of four screening methods for cervical neoplasia.
Wu S; Meng L; Wang S; Ma D
Int J Gynaecol Obstet; 2005 Nov; 91(2):189-93. PubMed ID: 16183061
[TBL] [Abstract][Full Text] [Related]
24. Liquid-based Papanicolaou smears without a transformation zone component: should clinicians worry?
Baer A; Kiviat NB; Kulasingam S; Mao C; Kuypers J; Koutsky LA
Obstet Gynecol; 2002 Jun; 99(6):1053-9. PubMed ID: 12052599
[TBL] [Abstract][Full Text] [Related]
25. Triage by HPV-DNA testing: is it useful in women with persistent minor smear abnormalities?
Pisal N; Sindos M; Chow C; Singer A
Acta Obstet Gynecol Scand; 2003 Jun; 82(6):575-7. PubMed ID: 12780430
[TBL] [Abstract][Full Text] [Related]
26. HPV test: antidote to ASCUS headache?
Titus K
CAP Today; 1996 Sep; 10(9):1, 52-4, 56-8. PubMed ID: 10166422
[No Abstract] [Full Text] [Related]
27. HPV testing alone is not as safe as cytology and selective HPV testing: AGAINST: There is powerful evidence for primary cervical screening.
Kitchener H
BJOG; 2016 Jan; 123(1):68. PubMed ID: 26527427
[No Abstract] [Full Text] [Related]
28. Detection of human papilloma virus in women referred for colposcopy. A comparison between different diagnostic methods.
Bodén E; Evander M; Wadell G; Bjersing L; von Schoultz B; Rylander E
Acta Obstet Gynecol Scand; 1990; 69(2):153-9. PubMed ID: 2166988
[TBL] [Abstract][Full Text] [Related]
29. [HPV-Dna hybridization allows differentiation of cervix lesions in PAP III cytologic findings].
Petry KU; Böhmer G; Linge G; Glaubitz M; Maschek H
Geburtshilfe Frauenheilkd; 1996 Oct; 56(10):509-12. PubMed ID: 9036061
[TBL] [Abstract][Full Text] [Related]
30. Correlation between atypical colposcopy findings and detection of human papillomavirus (HPV) infection of the uterine cervix.
Perovic M; Berisavac M; Kuljic-Kapulica N; Jovanovic T
Eur J Gynaecol Oncol; 2002; 23(1):42-4. PubMed ID: 11876390
[TBL] [Abstract][Full Text] [Related]
31. Clinical application of HPV typing in cervical cancer.
Namkoong SE
Int J Gynaecol Obstet; 1995 Jul; 49 Suppl():S59-67. PubMed ID: 7589742
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus coinfections of the vulva and uterine cervix.
Kulski JK; Demeter T; Rakoczy P; Sterrett GF; Pixley EC
J Med Virol; 1989 Mar; 27(3):244-51. PubMed ID: 2542434
[TBL] [Abstract][Full Text] [Related]
33. HPV testing in cervical cytology practice: it's all about choice.
Stoler MH
Acta Cytol; 2005; 49(2):117-9. PubMed ID: 15839612
[No Abstract] [Full Text] [Related]
34. [Molecular diagnosis of HPV infections].
Wentzensen N
Pathologe; 2011 Nov; 32(6):461-6. PubMed ID: 21845360
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for high-grade cervical intraepithelial neoplasia in patients with mild cytological dyskaryosis: human papillomavirus testing versus multivariate tree analysis of demographic data.
Sideri M; Spinaci L; Schettino F; Mezzetti M; Robertson C; Spolti N; Di Pace R; Crosignani P
Cancer Epidemiol Biomarkers Prev; 1998 Mar; 7(3):237-41. PubMed ID: 9521440
[TBL] [Abstract][Full Text] [Related]
36. [Comparision of cytological study results and data of bio-molecular assay hybrid capture II in patients with precancer of the cervix uteri].
Podistov IuI
Klin Lab Diagn; 2005 Aug; (8):43-5. PubMed ID: 16218339
[No Abstract] [Full Text] [Related]
37. Screening for genital human papillomavirus: results from an international validation study on human papillomavirus sampling techniques.
de Sanjosé S; Bosch XF; Muñoz N; Chichareon S; Ngelangel C; Balagueró L; Jacobs MV; Meijer CJ; Walboomers JM
Diagn Mol Pathol; 1999 Mar; 8(1):26-31. PubMed ID: 10408790
[TBL] [Abstract][Full Text] [Related]
38. Detection and typing of human papillomavirus infection affecting the cervix, vagina and vulva. Comparison of DNA hybridization with cytological, colposcopic and histological examinations.
Vuopala S; Pöllänen R; Kauppila A; Lehto VP
Arch Gynecol Obstet; 1993; 253(2):75-83. PubMed ID: 8215611
[TBL] [Abstract][Full Text] [Related]
39. Negative Roche cobas HPV testing in cases of biopsy-proven invasive cervical carcinoma, compared with Hybrid Capture 2 and liquid-based cytology.
Vasilyeva D; Tiscornia-Wasserman P; Gonzalez AA
J Am Soc Cytopathol; 2021; 10(2):128-134. PubMed ID: 32896510
[TBL] [Abstract][Full Text] [Related]
40. [Papillomavirus screening: shall it be performed systematically?].
Agius G; Beby-Defaux A
Transfus Clin Biol; 2003 Apr; 10(2):86-9. PubMed ID: 12763151
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
